Modification of antibody effector functions is commonly performed by chimerization or humanization. Cloning of antibody variable regions from hybridomas represents a first step that is frequently hampered by the expression of non-functionally rearranged variable regions in hybridoma cells that originate from MOPC21-derived fusion partners. We now present a simple method to clone functionally rearranged V-genes, based on V-gene-specific multiplex PCR screening. Using this method we document the expression of aberrant V-genes that originate from the original B-cell used for the hybridoma generation, not from the fusion partner, and are - thus - hybridoma specifi
Objectives We have studied the role of lymphoproliferative tumors in the pathogenesis of autoimmune ...
The isolation of the rearranged immunoglobulin genes from a hybridoma cell line, which is a prerequi...
For studying human antibody variable (V)-gene usage in any group of individuals or for the generatio...
Monoclonal antibodies are produced in cultured hybridoma cell lines, but these cells tend to be unst...
We describe a general approach to rapidly obtain the DNA sequence encoding the variable region of an...
We have designed a novel strategy for the isolation of the rearranged genomic fragments encoding the...
Cloning the correct VL kappa gene from hybridomas derived from MOPC-21 can be problematic because su...
Hybridomas, fusions of primary mouse B cells and myelomas, are stable, rapidly-proliferating cell li...
We describe a new method for amplification, by polymerase chain reaction (PCR), of rearranged segmen...
Tumor-specific markers are important in identifying and tracking malignant cells. In this regard, fu...
A hybridoma producing a polyspecific human monoclonal IgM antibody (named CB03) has been derived fro...
One way to achieve variable region diversity in the antibodies produced by B cells is by somatic mut...
Monoclonal antibodies are commonly assumed to be monospecific, but anecdotal studies have reported g...
Mammalian cells are the host of choice for the production of the majority of proteins with therapeut...
The technique of V region PCR to clone antibody V regions from hybridomas has been extensively used....
Objectives We have studied the role of lymphoproliferative tumors in the pathogenesis of autoimmune ...
The isolation of the rearranged immunoglobulin genes from a hybridoma cell line, which is a prerequi...
For studying human antibody variable (V)-gene usage in any group of individuals or for the generatio...
Monoclonal antibodies are produced in cultured hybridoma cell lines, but these cells tend to be unst...
We describe a general approach to rapidly obtain the DNA sequence encoding the variable region of an...
We have designed a novel strategy for the isolation of the rearranged genomic fragments encoding the...
Cloning the correct VL kappa gene from hybridomas derived from MOPC-21 can be problematic because su...
Hybridomas, fusions of primary mouse B cells and myelomas, are stable, rapidly-proliferating cell li...
We describe a new method for amplification, by polymerase chain reaction (PCR), of rearranged segmen...
Tumor-specific markers are important in identifying and tracking malignant cells. In this regard, fu...
A hybridoma producing a polyspecific human monoclonal IgM antibody (named CB03) has been derived fro...
One way to achieve variable region diversity in the antibodies produced by B cells is by somatic mut...
Monoclonal antibodies are commonly assumed to be monospecific, but anecdotal studies have reported g...
Mammalian cells are the host of choice for the production of the majority of proteins with therapeut...
The technique of V region PCR to clone antibody V regions from hybridomas has been extensively used....
Objectives We have studied the role of lymphoproliferative tumors in the pathogenesis of autoimmune ...
The isolation of the rearranged immunoglobulin genes from a hybridoma cell line, which is a prerequi...
For studying human antibody variable (V)-gene usage in any group of individuals or for the generatio...